MmpL3 is a lipid transporter that binds trehalose monomycolate and phosphatidylethanolamine
- PMID: 31113875
- PMCID: PMC6561238
- DOI: 10.1073/pnas.1901346116
MmpL3 is a lipid transporter that binds trehalose monomycolate and phosphatidylethanolamine
Abstract
The cell envelope of Mycobacterium tuberculosis is notable for the abundance of mycolic acids (MAs), essential to mycobacterial viability, and of other species-specific lipids. The mycobacterial cell envelope is extremely hydrophobic, which contributes to virulence and antibiotic resistance. However, exactly how fatty acids and lipidic elements are transported across the cell envelope for cell-wall biosynthesis is unclear. Mycobacterial membrane protein Large 3 (MmpL3) is essential and required for transport of trehalose monomycolates (TMMs), precursors of MA-containing trehalose dimycolates (TDM) and mycolyl arabinogalactan peptidoglycan, but the exact function of MmpL3 remains elusive. Here, we report a crystal structure of Mycobacterium smegmatis MmpL3 at a resolution of 2.59 Å, revealing a monomeric molecule that is structurally distinct from all known bacterial membrane proteins. A previously unknown MmpL3 ligand, phosphatidylethanolamine (PE), was discovered inside this transporter. We also show, via native mass spectrometry, that MmpL3 specifically binds both TMM and PE, but not TDM, in the micromolar range. These observations provide insight into the function of MmpL3 and suggest a possible role for this protein in shuttling a variety of lipids to strengthen the mycobacterial cell wall.
Keywords: MmpL3 transporter; X-ray crystallography; cell-wall biogenesis; mycobacterial membrane protein Large; native mass spectrometry.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Structures of the mycobacterial membrane protein MmpL3 reveal its mechanism of lipid transport.PLoS Biol. 2021 Aug 12;19(8):e3001370. doi: 10.1371/journal.pbio.3001370. eCollection 2021 Aug. PLoS Biol. 2021. PMID: 34383749 Free PMC article.
-
Two Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria.mBio. 2019 Jun 25;10(3):e00850-19. doi: 10.1128/mBio.00850-19. mBio. 2019. PMID: 31239378 Free PMC article.
-
Targeting MmpL3 for anti-tuberculosis drug development.Biochem Soc Trans. 2020 Aug 28;48(4):1463-1472. doi: 10.1042/BST20190950. Biochem Soc Trans. 2020. PMID: 32662825 Free PMC article. Review.
-
MmpL3 is the flippase for mycolic acids in mycobacteria.Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):7993-7998. doi: 10.1073/pnas.1700062114. Epub 2017 Jul 11. Proc Natl Acad Sci U S A. 2017. PMID: 28698380 Free PMC article.
-
MmpL3 inhibitors as antituberculosis drugs.Eur J Med Chem. 2020 Aug 15;200:112390. doi: 10.1016/j.ejmech.2020.112390. Epub 2020 May 4. Eur J Med Chem. 2020. PMID: 32447196 Review.
Cited by
-
Effect of Mycolic Acids on Host Immunity and Lipid Metabolism.Int J Mol Sci. 2023 Dec 28;25(1):396. doi: 10.3390/ijms25010396. Int J Mol Sci. 2023. PMID: 38203570 Free PMC article. Review.
-
An essential periplasmic protein coordinates lipid trafficking and is required for asymmetric polar growth in mycobacteria.Elife. 2022 Nov 8;11:e80395. doi: 10.7554/eLife.80395. Elife. 2022. PMID: 36346214 Free PMC article.
-
Molecular Modeling and Simulation of the Mycobacterial Cell Envelope: From Individual Components to Cell Envelope Assemblies.J Phys Chem B. 2023 Dec 28;127(51):10941-10949. doi: 10.1021/acs.jpcb.3c06136. Epub 2023 Dec 13. J Phys Chem B. 2023. PMID: 38091517 Free PMC article. Review.
-
Molecular Mechanisms of MmpL3 Function and Inhibition.Microb Drug Resist. 2023 May;29(5):190-212. doi: 10.1089/mdr.2021.0424. Epub 2023 Feb 21. Microb Drug Resist. 2023. PMID: 36809064 Free PMC article. Review.
-
The multi-target aspect of an MmpL3 inhibitor: The BM212 series of compounds bind EthR2, a transcriptional regulator of ethionamide activation.Cell Surf. 2021 Nov 23;7:100068. doi: 10.1016/j.tcsw.2021.100068. eCollection 2021 Dec. Cell Surf. 2021. PMID: 34888432 Free PMC article.
References
-
- Wallis R. S., et al. , Tuberculosis: Advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers. Lancet Infect. Dis. 16, e34–e46 (2016). - PubMed
-
- World Health Organization , Global Tuberculosis Report 2017 (World Health Organization, Geneva, 2017).
-
- Brennan P. J., Nikaido H., The envelope of mycobacteria. Annu. Rev. Biochem. 64, 29–63 (1995). - PubMed
-
- Camacho L. R., et al. , Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier. J. Biol. Chem. 276, 19845–19854 (2001). - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
